Skip to main content
CRBU logo

CRBU

Caribou Biosciences, Inc.

$0.29

5.64%

Trade Ideas Performance

Latest Closed Trade Idea

$0.29

5.64%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

46

Social

11

About

Events of Caribou Biosciences, Inc. (CRBU)

On October 6, 2026, Caribou Biosciences announced a major restructuring, discontinuing clinical trials for its lead allogeneic CAR-T cell therapy programs, vispa-cel and CB-011, and reducing its workforce to explore strategic alternatives. This news led to a significant stock decline, including a -45.6% drop on October 7, 2026, and an all-time low of $0.4135 on October 29, 2026, resulting in a -77.37% decrease over the past six months. In November 2026, the company reported Q3 2026 financial results that beat analyst expectations for EPS and revenue, though revenue from licensing decreased compared to the prior year. Following these events, analysts downgraded the stock, and the consensus price target decreased.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)